查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678714

失眠治疗市场规模、份额、趋势分析报告：按类型、销售管道、地区、细分市场预测，2025-2030 年

Insomnia Therapeutics Market Size, Share & Trends Analysis Report By Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), By Sales Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

失眠治疗市场的成长与趋势

根据 Grand View Research, Inc. 的一份新报告，全球失眠治疗市场预计到 2030 年将达到 37.4 亿美元，2025 年至 2030 年的复合年增长率为 4.5%。

市场主要受到取得专利的分子、潜在临床候选药物、不断上升的压力水平以及越来越多的老年人难以入睡的推动。失眠症盛行率的上升、人们对失眠症认识的提高以及更安全药物的普及预计将推动收益成长。

据估计，失眠影响着全球约 35％ 的人口。失眠症有多种类型，包括入睡困难、睡眠维持困难，并且通常伴随频繁、过早醒来以及难以重新入睡。长期失眠会干扰您的日常生活并导致工作效率低下。如果不及时治疗，这种情况会导致严重的忧郁症和神经衰弱。

影响失眠治疗市场成长的因素包括压力水平的上升、市场上专利分子的存在、临床管线中的潜在药物、技术先进的医疗设备的引进以及老年人口的增加。人们越来越意识到睡眠不足对日常生活的影响，预计将增加各种失眠治疗方法的采用，从而导致失眠治疗市场的收益成长。

目前，治疗失眠最广泛使用的药物包括非专利非苯二氮平类药物和抗忧郁症，市面上还有一些较新的药物，如Orexin拮抗剂和褪黑激素拮抗剂。Eisai的 lemborexant 的推出预计将解决该领域尚未满足的医疗需求，并在预测期内推动市场成长。根据2015年联合国的报告，预计到2030年，60岁以上人口将增加56%，达到约14亿。这些数据表明，老年人口正在增加。由于这一人群更容易受到睡眠不足的影响，对失眠治疗的需求预计会增加。

失眠治疗市场报告重点

  • 苯二氮平类药物将占据市场主导地位，到 2024 年的份额将达到 29.1%。苯二氮平类药物可用于治疗与急性压力相关的失眠。预计抗忧郁症在预测期内将显着增长。
  • 非处方药 (OTC) 将引领市场，到 2024 年将占据 61.6% 的份额。由于人们对药物及其消费的认识不断提高，预计处方药治疗将在预测期内快速增长。
  • 北美失眠治疗市场将在 2024 年占据全球市场的主导地位，收益占有率为 35.4%。该地区市场的成长归因于该地区失眠盛行率的上升、意识层级的提高以及高昂的医疗支出。
  • 预计预测期内亚太地区失眠治疗市场将实现最快的复合年增长率，为 5.3%。亚太地区失眠治疗市场预计将见证失眠治疗市场的显着成长。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 失眠治疗市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析 – 波特五力分析
    • PESTLE分析

第 4 章失眠治疗市场：类型业务分析

  • 2024 年和 2030 年各类型的市场占有率
  • 类型细分仪表板
  • 2018 年至 2030 年按类型分類的市场规模、预测与趋势分析
  • 苯二氮平类
  • 非苯二氮平类
  • 抗忧郁症
  • Orexin拮抗剂
  • 褪黑激素拮抗剂
  • 其他的

第 5 章失眠治疗市场：销售管道业务分析

  • 2024 年及 2030 年销售管道市场占有率
  • 销售管道细分仪表板
  • 2018 年至 2030 年按销售管道分類的市场规模、预测与趋势分析
  • 处方药
  • 场外交易（OTC）

第六章 失眠治疗市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 市场规模、预测趋势分析，2018-2030
  • 北美洲
    • 按国家/地区，2018 年至 2030 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区，2018 年至 2030 年
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 按国家/地区，2018 年至 2030 年
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按国家/地区，2018 年至 2030 年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Takeda Pharmaceutical Company Limited
    • VANDA PHARMACEUTICALS
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV（Viatris Inc.）
    • Sumitomo Pharma Co., Ltd.
    • Sanofi
    • Paratek Pharmaceuticals, Inc.
    • Ebb Therapeutics（Kryo）
Product Code: GVR-2-68038-213-6

Insomnia Therapeutics Market Growth & Trends:

The global insomnia therapeutics market size is expected to reach USD 3.74 billion by 2030, registering a CAGR of 4.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the presence of patented molecules, potential clinical pipeline candidates, rising stress level, and increase in geriatric population who find it difficult to fall asleep. Increase in prevalence of insomnia & awareness about this condition and availability of safer drugs are anticipated to fuel revenue growth.

Insomnia is estimated to affect approximately 35% of the global population. Different patterns of the condition include difficulty in sleep initiation and maintenance, which is generally accompanied with frequent awakenings & awakening too early with trouble sleeping again. Long-term insomnia can hamper everyday life, which may result in nonproductive work hours. If left untreated, this condition may lead to severe depression and nervous breakdown of the patient.

Factors influencing insomnia therapeutics market growth include rising stress level, presence of patented molecules in the market, potential drugs in clinical pipeline, introduction of technologically advanced medical devices, and growing geriatric population. Growing awareness about the impact of sleep deprivation on everyday life is anticipated to increase adoption rate of various treatments for insomnia, which is expected to lead to revenue growth of the insomnia therapeutics market.

Currently, widely adopted treatment options for insomnia include generic nonbenzodiazepines and antidepressants even though other novel agents such as orexin antagonists and melatonin antagonists are available in the market. Launch of Eisai's Lemborexant is expected to cater to unmet medical needs in this segment and fuel growth of this market over the forecast period. According to United Nations (UN) report in 2015, population in the age group of 60 years and above is projected to grow by 56% and is expected to reach around 1.4 billion by 2030. These statistics indicate the growing geriatric population. Since this population base is more susceptible to sleep deprivation, the demand for insomnia therapeutics is anticipated to increase.

Insomnia Therapeutics Market Report Highlights:

  • Benzodiazepines dominated the market and accounted for a share of 29.1% in 2024. Benzodiazepines are useful for insomnia associated with acute stress. Antidepressants are expected to grow lucratively over the forecast period.
  • Over-the-counter (OTC) led the market and accounted for a share of 61.6% in 2024, owing to the increasing number of patients with insomnia. Prescription therapeutics are projected to grow rapidly over the forecast period, fueled by the increasing awareness regarding drugs and their consumption amongst people.
  • North America insomnia therapeutics market dominated the global market with a revenue share of 35.4% in 2024. Market growth in the region is due to the rising incidence of insomnia disorders, the increase in awareness levels, and high healthcare spending in this region.
  • Asia Pacific insomnia therapeutics market is expected to register the fastest CAGR of 5.3% in the forecast period. Asia Pacific insomnia therapeutics market is anticipated to witness significant growth in the insomnia therapeutics market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Sales Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Insomnia Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Insomnia Therapeutics Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Benzodiazepines
    • 4.4.1. Benzodiazepines Market, 2018 - 2030 (USD Million)
  • 4.5. Nonbenzodiazepines
    • 4.5.1. Nonbenzodiazepines Market, 2018 - 2030 (USD Million)
  • 4.6. Antidepressants
    • 4.6.1. Antidepressants Market, 2018 - 2030 (USD Million)
  • 4.7. Orexin Antagonists
    • 4.7.1. Orexin Antagonists Market, 2018 - 2030 (USD Million)
  • 4.8. Melatonin Antagonists
    • 4.8.1. Melatonin Antagonists Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Insomnia Therapeutics Market: Sales Channel Business Analysis

  • 5.1. Sales Channel Market Share, 2024 & 2030
  • 5.2. Sales Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
  • 5.4. Prescription
    • 5.4.1. Prescription Market, 2018 - 2030 (USD Million)
  • 5.5. Over-the-Counter (OTC)
    • 5.5.1. Over-the-Counter (OTC) Market, 2018 - 2030 (USD Million)

Chapter 6. Insomnia Therapeutics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Takeda Pharmaceutical Company Limited
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. VANDA PHARMACEUTICALS
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Merck & Co., Inc.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Pfizer Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Teva Pharmaceutical Industries Ltd.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Mylan N.V. (Viatris Inc.)
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Sumitomo Pharma Co., Ltd.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Sanofi
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Paratek Pharmaceuticals, Inc.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Ebb Therapeutics (Kryo)
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global insomnia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 5. Global insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 6. North America insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 8. North America insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 9. U.S. insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 10. U.S. Insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 11. Canada insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 12. Canada insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 13. Mexico insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 14. Mexico insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 15. Europe insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 16. Europe insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 17. Europe insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 18. UK insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 19. UK Insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 20. Germany insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 21. Germany insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 22. France insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 23. France Insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 24. Italy insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 25. Italy insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 26. Spain insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 27. Spain insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 28. Norway insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 29. Norway Insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 30. Denmark insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 31. Denmark insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 32. Sweden insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 33. Sweden insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 37. Japan insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 38. Japan insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 39. China insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 40. China insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 41. India insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 42. India insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 43. Australia insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 44. Australia insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 45. South Korea insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 46. South Korea insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 47. Thailand insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 48. Thailand insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 49. Latin America insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 50. Latin America insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 51. Latin America insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 52. Brazil insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 53. Brazil insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 54. Argentina insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 55. Argentina insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa Insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 59. South Africa insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 60. South Africa insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 63. UAE insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 64. UAE insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 65. Kuwait insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 66. Kuwait insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Insomnia therapeutics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and sales channel outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Insomnia therapeutics market dynamics
  • Fig. 12 Insomnia therapeutics market: Porter's five forces analysis
  • Fig. 13 Insomnia therapeutics market: PESTLE analysis
  • Fig. 14 Insomnia therapeutics market: Type segment dashboard
  • Fig. 15 Insomnia therapeutics market: Type market share analysis, 2024 & 2030
  • Fig. 16 Benzodiazepines market, 2018 - 2030 (USD Million)
  • Fig. 17 Nonbenzodiazepines market, 2018 - 2030 (USD Million)
  • Fig. 18 Antidepressants market, 2018 - 2030 (USD Million)
  • Fig. 19 Orexin antagonists market, 2018 - 2030 (USD Million)
  • Fig. 20 Melatonin antagonists market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 Insomnia therapeutics market: Sales channel segment dashboard
  • Fig. 23 Insomnia therapeutics market: Sales channel market share analysis, 2024 & 2030
  • Fig. 24 Prescription market, 2018 - 2030 (USD Million)
  • Fig. 25 Over-the-counter (OTC) market, 2018 - 2030 (USD Million)
  • Fig. 26 Insomnia therapeutics market revenue, by region
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 41 France country dynamics
  • Fig. 42 France insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark country dynamics
  • Fig. 52 Denmark insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea country dynamics
  • Fig. 63 South Korea insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 71 MEA insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework